Literature DB >> 16549404

ADHD drugs and cardiovascular risk.

Steven E Nissen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16549404     DOI: 10.1056/NEJMp068049

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  76 in total

1.  Late potentials in the signal-averaged electrocardiogram in pre-pubertal children with ADHD, before and after methylphenidate treatment.

Authors:  Eitan Nahshoni; Pavel Golubchik; Jonathan Glazer; Jonathan Sever; Boris Strasberg; Shula Imbar; Gal Shoval; Abraham Weizman; Gil Zalsman
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-12-11       Impact factor: 4.785

2.  Possible adverse events in children treated by manual therapy: a review.

Authors:  B Kim Humphreys
Journal:  Chiropr Osteopat       Date:  2010-06-02

Review 3.  An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults.

Authors:  Timothy E Wilens; Nicholas R Morrison; Jefferson Prince
Journal:  Expert Rev Neurother       Date:  2011-10       Impact factor: 4.618

Review 4.  The QT interval and psychotropic medications in children: recommendations for clinicians.

Authors:  Paul McNally; Fiona McNicholas; Paul Oslizlok
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-29       Impact factor: 4.785

Review 5.  Sociocultural issues in african american and Hispanic minorities seeking care for attention-deficit/hyperactivity disorder.

Authors:  Rahn K Bailey; Marisela C Jaquez-Gutierrez; Manisha Madhoo
Journal:  Prim Care Companion CNS Disord       Date:  2014-07-03

Review 6.  Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function.

Authors:  Benedetto Vitiello
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-04

7.  Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers : is it justified?

Authors:  Jaswinder K Ghuman; Harinder S Ghuman
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

Review 8.  Prescription stimulant medication misuse: Where are we and where do we go from here?

Authors:  Lisa L Weyandt; Danielle R Oster; Marisa E Marraccini; Bergljot Gyda Gudmundsdottir; Bailey A Munro; Emma S Rathkey; Alison McCallum
Journal:  Exp Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.157

9.  Update on adult attention-deficit/hyperactivity disorder.

Authors:  Paul Hammerness; Craig Surman; Katherine Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

Review 10.  Association of ADHD medications with the risk of cardiovascular diseases: a meta-analysis.

Authors:  Hui Liu; Wenjing Feng; Dongfeng Zhang
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-08-24       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.